T cell receptor β-chain repertoires are nonrandomly selected in responses to HLA-DR1

Transplantation

Volumn 61, Issue 7, 1996, Pages 1084-1094

  Hand, Susan L ^a,b   Alter, Mark D ^a   Finn, Olivera J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; HLA DR1 ANTIGEN; T LYMPHOCYTE RECEPTOR BETA CHAIN; LYMPHOCYTE ANTIGEN RECEPTOR;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; HUMAN; HUMAN CELL; KIDNEY ALLOGRAFT; MIXED LYMPHOCYTE REACTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE; GENETICS; IMMUNOLOGY; MOLECULAR GENETICS;

AMINO ACID SEQUENCE; BASE SEQUENCE; CELL LINE; HLA-DR1 ANTIGEN; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; T-LYMPHOCYTES;

EID: 0029664601     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199604150-00017     Document Type: Article

References (54)

1. Wilson DB, Bluthe JL, Nowell PC. Quantitative studies on the mixed lymphocyte reaction. III. Kinetics of the response. J Exp Med 1968; 128: 1157.
2. Fisher-Lindahl K, Wilson DB. Histocompatibility antigen-activated cytotoxic T lymphocytes. II. Estimates of the frequency and specificity of precursors. J Exp Med 1977; 145: 508.
3. Garman RD, Ko J-L, Vulpe CD, Raulet DH. T cell receptor variable region gene usage in T cell populations. Proc Natl Acad Sci USA 1986; 83: 3987.
4. bm12-reactive T cells. J Exp Med 1989; 169: 115.
5. Geiger MJ, Gorski J, Eckels DD. T cell receptor gene segment utilization by HLA-DR1-alloreactive T cell clones. J Immunol 1991; 147: 2082.
6. Hurley CK, Steiner N, Wagner A, Geiger MJ, Eckels DD, Rosen-Bronson S. Nonrandom T cell receptor usage in the allorecognition of HLA-DR1 microvariation. J Immunol 1993; 150: 1314.
7. Beall SS, Lawrence JV, Bradley DA, Mattson DH, Singer DS, Biddison WE. β-chain gene rearrangements and Vβ gene usage in DPw2-specific T cells. J Immunol 1987; 139: 1320.
8. Miceli MC, Finn OJ. T cell receptor β chain selection in human allograft rejection. J Immunol 1989; 142: 81.
9. Bragado R, Lauzurica P, Lopez D, Lopez de Castro JA. T cell receptor Vβ gene usage in a human alloreactive response: shared structural features among HLA-B27-specific T cell clones. J Exp Med 1990; 171: 1189.
10. Hall BL, Finn OJ. T cell receptor Vβ gene usage in allograft-derived cell lines analyzed by a polymerase chain reaction technique. Transplantation 1992; 53: 1088.
11. Hand SL, Hall BL, Finn OJ. T cell receptor Vβ gene usage in HLA-DR1-reactive T cell populations: the predominance of Vβ8. Transplantation 1992; 54: 357.
12. Lauzurica P, Bragado R, Lopez D, Galocha B, Lopez de Castro J. Asymmetric selection of T cell antigen receptor α- and β-chains in HLA-B27 alloreactivity. J Immunol 1992; 148: 3624.
13. Goronzy JJ, Xie C, Hu W, Lundy SK, Weyand CM. Restrictions in the repertoire of allospecific T cells: contributions of the α-helical sequence polymorphism of HLA-DR molecules. J Immunol 1993; 151: 825.
14. Yamanaka K, Kwok WW, Mickelson EM, Masewicz S, Nepom GT. T cell receptor Vβ selectivity in T cell clones alloreactive to HLA-Dw14. Hum Immunol 1992; 33: 57.
15. Davis MM, Bjorkman PJ. T cell antigen receptor genes and T cell recognition. Nature 1988; 334: 395.
16. Chothia C, Boswell DR, Lesk AM. The outline structure of the T-cell αβ receptor. EMBO J 1988; 7: 3745.
17. Fink PJ, Matis LA, McElligott DL, Bookman M, Hedrick SM. Correlations between T cell specificity and the structure of the antigen receptor. Nature 1986; 321: 219.
18. Winoto A, Urban JL, Lan NC, Goverman J, Hood L, Hansburg D. Predominant use of a Vα gene segment in mouse T cell receptors for cytochrome c. Nature 1986; 324: 679.
19. Sorger SB, Hedrick SM, Fink PJ, Bookman MA, Matis LA. Generation of diversity in T cell receptor repertoire specific for pigeon cytochrome c. J Exp Med 1987; 165: 279.
20. Morel PA, Livingstone AM, Fathman CG. Correlation of T cell receptor Vβ gene family with MHC restriction. J Exp Med 1987; 166: 583.
21. b/TNP response. Nature 1987; 326: 307.
22. Moss PAH, Moots RJ, Rosenberg WMC, et al. Extensive conservation of α and β chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide. Proc Natl Acad Sci USA 1991; 88: 8987.
23. Jorgensen JL, Esser U, Fazekas de St. Groth B, Reay PA, Davis MM. Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature 1992; 355: 224.
24. Bentley GA, Boulot G, Karjalainen K, Mariuzza RA. Crystal structure of the beta chain of a T cell antigen receptor. Science 1995; 267: 1984.
25. Matzinger P, Bevan MJ. Why do so many lymphocytes respond to major histocompatibility antigens? Cell Immunol 1977; 29: 1.
26. b by alloreactive cytotoxic T lymphocytes. Nature 1989; 341: 749.
27. Hunt HD, Munitz TI, Pease LR. Alloreactive cytotoxic T lymphocytes recognize epitopes determined by both the a helices and β sheets of the class I peptide binding site. J Exp Med 1992; 175: 821.
28. Marrack P, Kappler J. T cells can distinguish between allogeneic major histocompatibility complex products on different cell types. Nature 1988; 332: 840.
29. Molina IJ, Huber BT. The expression of a tissue-specific self-peptide is required for allorecognition. J Immunol 1990; 144: 2082.
30. Santamaria P, Boyce-Jacino MT, Lindstrom AL, Rich SS, Faras AJ, Barbosa JJ. Alloreactive T cells can distinguish between the same human class II MHC products on different B cell lines. J Immunol 1991; 146: 1822.
31. Rotzschke O, Falk K, Faath S, Rammensee H-G. On the nature of peptides involved in T cell alloreactivity. J Exp Med 1991; 174: 1059.
32. Elliott TJ, Eisen HN. Allorecognition of purified major histocompatibility complex glycoproteins by cytotoxic T lymphocytes. Proc Natl Acad Sci USA 1988; 85: 2728.
33. Termijtelen A. T cell allorecognition of HLA class II. Hum Immunol 1990; 28: 1.
34. Aosai F, Ohlen C, Ljunggren H-G, et al. Different types of allospecific CTL clones identified by their ability to recognize peptide loading-defective target cells. Eur J Immunol 1991; 21: 2767.
35. Berkowitz N, Braunstein NS. T cell responses specific for subregions of allogeneic MHC molecules. J Immunol 1992; 148: 309.
36. Goss JA, Pyo R, Flye MW, Connolly JM, Hansen TH. Major histocompatibility complex-specific prolongation of murine skin and cardiac allograft survival after in vivo depletion of Vβ+ T cells. J Exp Med 1993; 177: 35.
37. George A, Dazzi F, Lynch J, et al. Biased TCR gene usage in alloreactive T cells specific for a structurally dissimilar MHC alloantigen. Int Immunol 1994; 6: 1785.
38. Jaraquemada D, Marti M, Martin R, Wagner A, MacFarland HF, Rosen-Bronson S. Different requirements of ICAM-1/LFA-1 adhesion in allorecognition and self-restricted antigen recognition by class II-specific T cell clones. Eur J Immunol 1994; 24: 947.
39. Hand SL, Hall BL, Finn OJ. T cell receptor gene usage and expression in renal allograft-derived T cell lines. Hum Immunol 1990; 28: 82.
40. Hall BL, Finn OJ. PCR-based analysis of the T-cell receptor Vβ multigene family: experimental parameters affecting its validity. Biotechniques 1992; 13: 248.
41. Hand SL, Hall BL, Finn OJ. Association of TCR expression with MHC recognition. In: Gallagher G, Rees RC, Reynolds CW, eds. Tumour immunobiology: a practical approach. Oxford, UK: IRL Press, 1993: 143.
42. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
43. Sanger F, Niklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977; 74: 5463.
44. Yanagi Y, Yoshikai Y, Leggett K, Clark SP, Aleksander I, Mak TW. A human T cell specific cDNA clone encodes a protein having extensive homology to immunoglobulin chains. Nature 1984; 308: 145.
45. Siu G, Strauss EC, Lai E, Hood LE. Analysis of a human Vβ gene subfamily. J Exp Med 1986; 164: 1600.
46. Cambon-Thomsen A, Thomsen M, Abbal M, Sommer E, Calot M, Ohayon E. A new HLA-D specificity associated with DR blank: D-BON. 1986; 27: 256.
47. Coppin HL, Avoustin P, Fabron J, et al. Evolution of the HLA-DR1 gene family: structural and functional analysis of the new allele "DR-BON." J Immunol 1990; 144: 984.
48. Eckels DD, Geiger MJ, Sell TW, Gorski JA. Involvement of class II β-chain amino acid residues 85 and 86 in T-cell allorecognition. Hum Immunol 1990; 27: 240.
49. Robinson MA. The human T cell receptor β-chain gene complex contains at least 57 variable gene segments: identification of six Vβ genes in four new gene families. J Immunol 1991; 146: 4392.
50. Hall BL. T cell receptor beta chain variable region usage in T cells infiltrating human renal allografts [Dissertation]. Duke University, Durham, NC, 1991.
51. Hall BL, Hand SL, Alter MD, Kirk AD, Finn OJ. Variables affecting the T cell receptor Vβ repertoire heterogeneity of T cells infiltrating human renal allografts. Transplant Immunol 1993; 1: 217.
52. Concannon P, Pickering LA, Kung P, Hood L. Diversity and structure of human T cell receptor β-chain variable region genes. Proc Natl Acad Sci USA 1986; 83: 6598.
53. Kimura N, Toyonaga B, Yoshikai Y, et al. Sequences and diversity of human T cell receptor β chain variable region genes. J Exp Med 1986; 164: 739.
54. Panina-Bordignon P, Corradin G, Roosnek E, Sette A, Lanzavecchia A. Recognition by class II alloreactive T cells of processed determinants from human serum proteins. Science 1991; 252: 1548.